Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 October 2019 | Story Xolisa Mnukwa | Photo Barend Nagel
Braille Signage
Big on Braille: Members of the Kovsie community who are living with visual impairments can now access directions through the new braille system.

The University of the Free State (UFS) commemorate World Sight Day, which is celebrated annually on the second Thursday of October. The day has been set aside and aimed at drawing attention to blindness and vision. This was originally initiated by the #SightFirstCampaign of the Lions Club International Foundation in 2000. 
The university aims to contribute to the development and social justice of all students through the production of globally competitive graduates. Thus, the development and implementation of co-curricular programmes, activities, services, and mutual infrastructure will allow for humanising daily lived experiences among students, which are essential for universal access, student academic success, social behaviour, engagement, and an inclusive institutional culture.

With this in mind, the university rolled out a capital project that included the construction of tactile pathways with braille indicators on the pathways, designed to support and caution pedestrians who are blind or visually impaired. The indicators are universally accessible, because it includes Braille and text. The text then gives indications to new students who are also struggling to find their way around campus.

A UFS Bachelor of Social Sciences student who dreams of becoming a social worker, Tshegofatso Nkatlholang, who was born partially blind, but is now completely blind is motivated by the prospect of living a life where she has the ability to help the less fortunate. Her opinion of the construction and implementation of the new tactile pathways on the UFS Bloemfontein Campus is that they are extremely helpful. She went on to say, “That is my road, and I am grateful for a university that strives to operate an inclusive infrastructural environment where I don’t feel sidelined.”
Kovsie student Keamogetswe Mbele was born partially blind with very low vision, eventually losing her eyesight. She explained that she had no knowledge of the newly built braille indicators on the tactile pathways, but that she felt appreciative of the university’s initiative to constitute an inclusive academic and infrastructural environment for all students on campus. Motivated by her personal goals of independence and financial freedom, ‘Kamo’, as her peers refer to her, is determined to live a prosperous academic life throughout the course of her studies at the UFS.

According to Mookgo Moloi, a Kovsie student who was not born blind but gradually lost her sight at the age of 15, said, “Life on campus is very caring”. She reflected on the opportunities, as well as the technical and emotional support that the Center for Universal Access and Disability Support (CUADS) has provided her, which has made her academic career a lot easier, and more advantageous for her to graduate. 
CUADS further strives to facilitate, create opportunities, and enhance students’ understanding of multiple intersections and ways of being that are consistent with human rights and the principles of social justice.




News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept